Close collaboration with Massachusetts

The Capital Region of Denmark, the Region Zealand and the Region Skåne have entered into a collaboration agreement with the American state of Massachusetts. The agreement assists in developing and strengthening the collaboration in the health sector, focusing particularly on research and business development within bio-tech, medicine and the medico-industry; the Life Science area.

Collaboration ​​between two of the world’s strongest Life Science clusters

Massachusetts is the home of some of the world’s strongest business and research clusters within bio-tech, medicine and the medico industry. The state has more than 500 bio-tech companies, and added to this, are very strong research communities at universities such as the Massachusetts Institute of Technology and Harvard, as well as a number of strong university hospitals.

In the Øresund Region, Life Science is concentrated in the Danish-Swedish Medicon Valley, which is known as one of Europe’s strongest clusters in the area. The Øresund Region is also home to a very strong research community within health, at universities and in hospitals.

Great sig​​nificance for research and networks

The agreement is to contribute to intensified research collaboration, exchange of researchers and students between the capital region and Massachusetts. This helps strengthen company networks and promote business development, and it facilitates access to American research funds.

Ambass​ador’s programme as leverage

Supported by the Growth Forum of the Capital City, the Medicon Valley Alliance has set up an ambassador’s programme, where posted “Life Science ambassadors” help Danish-Swedish Life Science enterprises and institutions to internationalise.

 

Facts:

​The collaboration agreement between the Commonwealth of Massachusetts and the Capital Region of Denmark is to:

 

  • Promote exchange of researchers and students.
  • Encourage activities aimed at strengthening research collaboration in Life Science.
  • Identify special projects or partnerships which may lead to new or strengthened research collaborations.
  • Identify and use government resources and programmes to underpin collaboration and commercialisation of research and development projects as well as results.
Establish frameworks where all parties can join common research and development projects which may develop new products and processes for commercial exploitation on the global markets.


Responsible editor